These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21737846)

  • 21. Calcium oxalate crystal deposition in metabolic syndrome model rat kidneys.
    Okamoto M; Kohjimoto Y; Iba A; Saji F; Hara I; Shigematsu T
    Int J Urol; 2010 Dec; 17(12):996-1003. PubMed ID: 21091796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrolithiasis in children.
    Valentini RP; Lakshmanan Y
    Adv Chronic Kidney Dis; 2011 Sep; 18(5):370-5. PubMed ID: 21896379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New pathophysiologic aspects of nephrolithiasis].
    Hess B
    Schweiz Med Wochenschr; 1989 Jul; 119(26):929-34. PubMed ID: 2678432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease.
    Karabacak OR; Ipek B; Ozturk U; Demirel F; Saltas H; Altug U
    Urology; 2010 Jul; 76(1):238-41. PubMed ID: 20350756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric urinary stone disease--does age matter?
    Kalorin CM; Zabinski A; Okpareke I; White M; Kogan BA
    J Urol; 2009 May; 181(5):2267-71; discussion 2271. PubMed ID: 19296968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor.
    Tekin A; Tekgul S; Atsu N; Sahin A; Ozen H; Bakkaloglu M
    J Urol; 2000 Jul; 164(1):162-5. PubMed ID: 10840454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of renal calculi.
    Miller NL; Evan AP; Lingeman JE
    Urol Clin North Am; 2007 Aug; 34(3):295-313. PubMed ID: 17678981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, demographic, and laboratory characteristics of children with nephrolithiasis.
    Sas DJ; Becton LJ; Tutman J; Lindsay LA; Wahlquist AH
    Urolithiasis; 2016 Jun; 44(3):241-6. PubMed ID: 26467033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-Occurrence of Asthma and Nephrolithiasis in Children.
    Kartha GK; Li I; Comhair S; Erzurum SC; Monga M
    PLoS One; 2017; 12(1):e0168813. PubMed ID: 28081237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome and uric acid nephrolithiasis.
    Sakhaee K; Maalouf NM
    Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney disease in kidney stone formers.
    Rule AD; Krambeck AE; Lieske JC
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2069-75. PubMed ID: 21784825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.